Renal amyloidosis surgery: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
==Indications==  
==Indications==  


*Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
*In renal amyloidosis, surgery is usually reserved for patients developed with end stage renal disease.<ref name="pmid225623702">{{cite journal |vauthors=Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS |title=Outcome of patients with amyloidosis after renal transplantation: a single-center experience |journal=Int J Artif Organs |volume=35 |issue=6 |pages=444–9 |date=June 2012 |pmid=22562370 |doi=10.5301/ijao.5000091 |url=}}</ref>
**[Indication 1]
**[Indication 2]
**[Indication 3]
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
**[Indication 1]
**[Indication 2]
**[Indication 3]


==Surgery==
==Surgery==


=== Renal transplantation ===
*The patients with renal amyloidosis are good candidates for transplantation.<ref name="pmid22562370">{{cite journal |vauthors=Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS |title=Outcome of patients with amyloidosis after renal transplantation: a single-center experience |journal=Int J Artif Organs |volume=35 |issue=6 |pages=444–9 |date=June 2012 |pmid=22562370 |doi=10.5301/ijao.5000091 |url=}}</ref>
*The patients with renal amyloidosis are good candidates for transplantation.<ref name="pmid22562370">{{cite journal |vauthors=Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS |title=Outcome of patients with amyloidosis after renal transplantation: a single-center experience |journal=Int J Artif Organs |volume=35 |issue=6 |pages=444–9 |date=June 2012 |pmid=22562370 |doi=10.5301/ijao.5000091 |url=}}</ref>
*In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.<ref name="pmid24497558">{{cite journal |vauthors=Mahmood S, Palladini G, Sanchorawala V, Wechalekar A |title=Update on treatment of light chain amyloidosis |journal=Haematologica |volume=99 |issue=2 |pages=209–21 |date=February 2014 |pmid=24497558 |pmc=3912950 |doi=10.3324/haematol.2013.087619 |url=}}</ref>
*In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.<ref name="pmid24497558">{{cite journal |vauthors=Mahmood S, Palladini G, Sanchorawala V, Wechalekar A |title=Update on treatment of light chain amyloidosis |journal=Haematologica |volume=99 |issue=2 |pages=209–21 |date=February 2014 |pmid=24497558 |pmc=3912950 |doi=10.3324/haematol.2013.087619 |url=}}</ref>

Revision as of 00:18, 28 June 2018

Renal amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Renal amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:Renal amyloidosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal amyloidosis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal amyloidosis surgery

CDC on Renal amyloidosis surgery

Renal amyloidosis surgery in the news

Blogs on Renal amyloidosis surgery

Directions to Hospitals Treating Cystic fibrosis

Risk calculators and risk factors for Renal amyloidosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview

Indications

  • In renal amyloidosis, surgery is usually reserved for patients developed with end stage renal disease.[1]

Surgery

Renal transplantation

  • The patients with renal amyloidosis are good candidates for transplantation.[2]
  • In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.[3]

References

  1. Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS (June 2012). "Outcome of patients with amyloidosis after renal transplantation: a single-center experience". Int J Artif Organs. 35 (6): 444–9. doi:10.5301/ijao.5000091. PMID 22562370.
  2. Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS (June 2012). "Outcome of patients with amyloidosis after renal transplantation: a single-center experience". Int J Artif Organs. 35 (6): 444–9. doi:10.5301/ijao.5000091. PMID 22562370.
  3. Mahmood S, Palladini G, Sanchorawala V, Wechalekar A (February 2014). "Update on treatment of light chain amyloidosis". Haematologica. 99 (2): 209–21. doi:10.3324/haematol.2013.087619. PMC 3912950. PMID 24497558.

Template:WH Template:WS